kinlytic
Kinlytic (Urokinase) is a medication used to treat Coronary Thrombosis, Vascular Graft Occlusion, Myocardial Infarction, Pulmonary Embolism.
Urokinase · by Microbix Biosystems
Key facts
- Active ingredient
- Urokinase
- Form
- Injectable
- Strength
- Urokinase 250,000 IU/VIAL · Urokinase 5,000 IU/VIAL · Urokinase 9,000 IU/VIAL
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- coronary thrombosis, vascular graft occlusion, myocardial infarction
- Manufacturer
- Microbix Biosystems
- FDA application
- BLA021846
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
- coronary thrombosis
- vascular graft occlusion
- myocardial infarction
- pulmonary embolism
- venous thrombosis
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Kinlytic treat?
- Kinlytic (Urokinase) may be used to treat coronary thrombosis, vascular graft occlusion, myocardial infarction, pulmonary embolism, venous thrombosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Kinlytic?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Kinlytic. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Kinlytic?
- Kinlytic is marketed by Microbix Biosystems. You can see Microbix Biosystems's full profile, rating, and other products on pharmaranks.
- Is Kinlytic a brand-name or generic drug?
- Kinlytic is a brand-name product with the active ingredient Urokinase.
- Is Kinlytic available over the counter?
- No. Kinlytic is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Kinlytic come in?
- Kinlytic is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Kinlytic FDA-registered?
- Kinlytic is on record with the U.S. FDA under application number BLA021846. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about UROKINASE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 338 reports naming UROKINASE — the active ingredient in Kinlytic, and the FDA flagged 99% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- anaemia18 reports
- hypotension18 reports
- pleural effusion16 reports
- pyrexia15 reports
- diarrhoea14 reports
- haematuria14 reports
- cerebral haemorrhage13 reports
- gastrointestinal haemorrhage13 reports
Read these as a signal, not a rate. A report does not mean UROKINASE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
akten
Lidocaine Hydrochloride
inderal la
Propranolol Hydrochloride
innopran xl
Propranolol Hydrochloride
lidocaine hydrochloride preservative free
Lidocaine Hydrochloride
pradaxa
Dabigatran Etexilate Mesylate
qbrelis
Lisinopril
Compare Kinlytic head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
kinlytic
New